Anti-IL-31 drug shows promise in itch management for atopic dermatitis
A phase-II study of a new systemic therapy for atopic dermatitis has found that the therapy, the anti-interleukin (IL)31 antibody...
top of page
it's where dermatology lives
Featured Posts
bottom of page